Last reviewed · How we verify

NVP-1805-R1and NVP-1805-R2

NVP Healthcare · Phase 1 active Small molecule

NVP-1805-R1and NVP-1805-R2 is a Small molecule drug developed by NVP Healthcare. It is currently in Phase 1 development.

At a glance

Generic nameNVP-1805-R1and NVP-1805-R2
SponsorNVP Healthcare
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about NVP-1805-R1and NVP-1805-R2

What is NVP-1805-R1and NVP-1805-R2?

NVP-1805-R1and NVP-1805-R2 is a Small molecule drug developed by NVP Healthcare.

Who makes NVP-1805-R1and NVP-1805-R2?

NVP-1805-R1and NVP-1805-R2 is developed by NVP Healthcare (see full NVP Healthcare pipeline at /company/nvp-healthcare).

What development phase is NVP-1805-R1and NVP-1805-R2 in?

NVP-1805-R1and NVP-1805-R2 is in Phase 1.

Related